Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Erdheim-Chester Disease, Langerhans cell histiocytosis, Rosai-Dorfman disease, or another similar rare disease affecting cells called histiocytes — this diagnosis can be based on tissue samples (biopsy), scan results, or your own report supported by medical records.
- You are able to read and communicate in English, either as confirmed by the research team or by your own report.
- You are willing to allow your past and future medical records related to your condition to be shared with the study registry.
Who may not be able to join:
- People who are not willing to sign a consent form agreeing to take part in the study.
- People who are under 18 years of age.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Eli Diamond, MD, Memorial Sloan Kettering Cancer Center
Phone: 212-610-0243
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Create registry for Erdheim-Chester Disease and Other Histiocytoses
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.